{"id":"W2059079195","doi":"10.1185/03007995.2015.1027185","title":"Single-pill combination therapy for type 2 diabetes mellitus: linagliptin plus empagliflozin","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Linagliptin; Empagliflozin; Medicine; Metformin; Type 2 diabetes; Type 2 Diabetes Mellitus; Pill; Glycemic; Diabetes mellitus; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003309106,0.0004403676,0.002414156,0.004773863,0.0002479387,0.001399085,0.0006075919,0.0009577925,0.0172782],"category_scores_gemma":[0.00630714,0.00024107,0.00248385,0.006725057,0.0003270822,0.00154163,0.0006000389,0.0005817445,0.002068632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006581578,"about_ca_system_score_gemma":0.001601994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006259719,"about_ca_topic_score_gemma":0.002225225,"domain_scores_codex":[0.9975873,0.0007601553,0.0007697861,0.0002295515,0.00059469,0.00005851495],"domain_scores_gemma":[0.9941631,0.0033736,0.00190591,0.0000794173,0.0003757646,0.0001022073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002029959,0.0001250523,0.001737639,0.4921461,0.003702691,0.0002920253,0.0001404744,0.00009159578,0.0008995185,0.0007350357,0.01701149,0.4810884],"study_design_scores_gemma":[0.006836826,0.002520975,0.02681602,0.5533044,0.03327453,0.005081851,0.0004662908,0.0005051174,0.001655612,0.002884525,0.3665143,0.0001394539],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003715304,0.9873815,0.0004941052,0.001063923,0.0003908612,0.0004177053,0.001679942,0.00003354369,0.004823155],"genre_scores_gemma":[0.04414178,0.9414562,0.004459363,0.003086268,0.001073545,0.001221425,0.002382636,0.00001911931,0.002159686],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0172782,"threshold_uncertainty_score":0.05780131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3692606348567541,"score_gpt":0.5114607009127419,"score_spread":0.1422000660559877,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}